Coverage
-
March 13, 2013
Mylan Pharmaceuticals Inc. has settled a patent infringement suit brought by Shionogi Inc. and Andrx Corp. over Mylan's bid to develop a generic equivalent of Shionogi's blood glucose drug Fortamet, Mylan announced Wednesday.
1 other articles on this case.
View all »